Results 261 to 270 of about 38,084 (311)

Aggregates in platelet concentrates

Vox Sanguinis, 2014
P. F. van der Meer, L. J. Dumont, M. Lozano, N. Bondar, J. Wong, S. Ismay, J. Pink, W. Nussbaumer, J. Coene, H. B. Feys, V. Compernolle, D. V. Devine, D. Howe, C. K. Lin, J. Sun, J. Ringwald, E. F. Strasser, R. Eckstein, A. Seltsam, P. Perseghin, P. Proserpio, S. Wakamoto, M. Akino, S. Takamoto, K. Tadokoro, D. Teo, P. H. Shu, S. S. Chua, T.
Pieter F, van der Meer, L J, Dumont, Miguel, Lozano, Noemi, Bondar, Janet, Wong, Sue, Ismay, Joanne, Pink, Walter, Nussbaumer, José, Coene, H B, Feys, Veerle, Compernolle, Dana V, Devine, David, Howe, Che Kit, Lin, Jenny, Sun, Juergen, Ringwald, Erwin F, Strasser, Reinhold, Eckstein, Axel, Seltsam, Paolo, Perseghin, Patrizia, Proserpio, Shinobu, Wakamoto, Mitsuaki, Akino, Shigeru, Takamoto, Kenji, Tadokoro, Diana, Teo, Pei Huey, Shu, Sze Sze, Chua, Teresa, Jimenez-Marco, Miguel, Lozano, Joan, Cid, Emma, Castro, Irene, Muñoz, Hans, Gulliksson, Per, Sandgren, Stephen, Thomas, Juraj, Petrik, Kevin, McColl, Hany, Kamel, James, Dugger, Joseph D, Sweeney, Jed B, Gorlin, Laurie J, Sutor, Doug, Heath, Merlyn H, Sayers   +44 more
openaire   +2 more sources

Prostaglandins in Platelet Aggregation

Scandinavian Journal of Clinical and Laboratory Investigation, 1969
The inhibitory effect of different prostaglandins on ADP-induced platelet aggregation has been studied using a technique similar to that of Born and O'Brien. PGE 1 has a high inhibiting capacity while PGE 2 shows about one-fifth of that. The activity of the other prostaglandins investigated (PGE 1–217, PGF 2 α, PGF 1 β and PGF 1 α) is much lower.
E, Irion, M, Blombäck
openaire   +2 more sources

Platelet aggregation in Hyperapobetalipoproteinemia

American Journal of Hematology, 1991
AbstractHyperapobetalipoproteinemia (HyperapoB) is a lipid disorder characterized by premature coronary disease, although the mechanisms have not been elucidated. Because abnormalities in platelet function may represent an enhanced susceptibility to coronary thrombosis, the aggregability of platelets was examined in hyperapoB subjects.
M, Miller, W, Bell, S, Plano, J, Connors, S, Kennedy, P, Kwiterovich   +5 more
openaire   +2 more sources

PROSTAGLANDINS AND PLATELET AGGREGATION

Acta Medica Scandinavica, 1981
ABSTRACTProstaglandins may induce or inhibit platelet aggregation and constrict or dilate blood vessels. Recent interest has focussed on prostaglandins which are derivatives of arachidonic acid including prostaglandin endoperoxides, thromboxane A2, prostaglandin E2, prostaglandin D2and prostacyclin.
openaire   +2 more sources

Purinoceptors and platelet aggregation

Journal of Autonomic Pharmacology, 1996
1. Adenosine 5'-diphosphate (ADP) is a physiologically important mediator, being released from damaged cells and from aggregating platelets. It acts on platelets to cause aggregation via a purinoceptor ('P2T-purinoceptor') at which adenosine 5'-triphosphate (ATP) is a competitive antagonist; however, the way in which it does so is not fully understood.
openaire   +4 more sources

Platelet aggregation by platelet-clumping substance

Thrombosis Research, 1974
Abstract The platelet-clumping substance isolated from rabbit plasma by the authors aggregated washed rabbit platelets, while ADP did not. The presence of AMP or adenosine did not inhibit the appearance of platelet aggregation induced by the clumping substance.
H, Yamazaki, T, Sano, T, Shimamoto, T, Shimamoto   +3 more
openaire   +2 more sources

Platelet Glycoproteins in Platelet Aggregation

Thrombosis and Haemostasis, 1979
Thrombin stimulation alters the membrane surface of platelets so that specific components on the membrane surface interact. To identify such “aggregation factors”, tne exposed membrane proteins of washed platelets were labeled by lactoperoxidase-catalyzed iodination and tested for their association with cytoskeletal structures.
David R. Phillips, Lisa K. Jennings, Harold H. Edwards   +2 more
openaire   +1 more source

Platelet aggregation and platelet-inhibiting drugs

Neurochemical Pathology, 1987
Platelet function may cause a progression of central gray matter damage after cerebrospinal hemorrhage or trauma because of the thrombotic occlusion of injured vessels or a vasospasm induced by extravasated blood. It has therefore been suggested that antiplatelet drugs could limit the extent of the neurological lesions produced by a spinal trauma.
openaire   +2 more sources

Piribedil and platelet aggregation.

Journal of medicine, 1984
Piribedil at high concentrations inhibits in vitro ADP and thrombin aggregation effect on the rabbit PRP.
VAIRO G, SCAFURO, Mariantonietta, LUCARELLI L, DI PAOLA E, MARMO E.   +4 more
openaire   +2 more sources

Methods for Platelet Aggregation

1972
The property of platelets to aggregate with appropriate stimuli is an essential feature of the haemostatic and thrombotic process. The study of aggregation in vitro has contributed much to our understanding of this process. The introduction of an absorptiometer (3, 20) together with continuous recording of the changes in optical density (10) have ...
openaire   +2 more sources